Conversion Labs Announces PDF Simpli Achieves Milestone Of Over one Million Registered Users #Conversion_Labs

Conversion Labs Announces PDF Simpli Achieves Milestone Of Over one Million Registered Users #Conversion_Labs

May 17, 2019 0 By NewsTakers

May 01, 2019 07:30 ET | Source: Conversion Labs, Inc.NEW YORK, May 01, 2019 (GLOBE NEWSWIRE) — Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce company focused on building and scaling innovative branded consumer products, today announced that the Company’s majority owned subsidiary, LegalSimpli Software LLC, achieved a milestone of over 1 million registered users of its PDF Simpli software product.
PDF Simpli, accessible at www.pdfsimpli.com , is a software as a service product that allows users to easily edit, convert, compress, split, or compress PDF files.
“The phenomenal growth of registered and subscribed users within our first year shows the size of the PDF market and that it is ripe for disruption.
To learn more about our corporate strategy, brands or for investor relations please visit www.conversionlabs.com or email us at info@conversionlabs.com.
Forward-Looking Statements
Such statements are subject to certain risks and uncertainties, which could cause Conversion Labs, Inc.’s actual results to differ materially from those anticipated by the forward-looking statements.
The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company’s ability to develop, market and sell its products; the expected benefits and efficacy of the Company’s products; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, clinical studies and future product commercialization; and, the Company’s business, research, product development, regulatory approval, marketing and distribution plans and strategies.
These and other factors are identified and described in more detail in our filings with the SEC.
Javascript
http://www.immudyne.com

Source link